Connect with us

Health

Team researching how effector and killer T cells can be controlled to destroy cancer cells that resist treatment – Californianewstimes.com

From left: Xinying Zong, PhD. Yongqiang Feng, PhD; and Dr. Xiaolei Hao (all of St. Jude Immunology) are studying ways to control effector and killer T cells to…

Published

on

Article feature image

From left: Xinying Zong, PhD. Yongqiang Feng, PhD; and Dr. Xiaolei Hao (all of St. Jude Immunology) are studying ways to control effector and killer T cells to destroy treatment-resistant cancer cells. Credits: St. Jude Children’s Research Hospital
Effector and killer T cells are a type of immune cell. Their job is to attack pathogens and cancer. These cells can also target normal cells that cause autoimmune diseases. However, when used properly, it can destroy cancer cells that resist treatment….

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending